Skip to main content Back to Top

ASHP Policy Position 2210

DRUG SAMPLES

Status: Current
To oppose drug sampling or similar drug marketing programs that circumvent appropriate pharmacy oversight or control.

This policy position supersedes ASHP policy position 9702.

Rationale

Drug marketing or sampling programs that involve physical samples can create a number of drug supply and patient risks if they are not subject to strict pharmacy control. However, “virtual” programs that allow pharmacy management of the supply (e.g., situations where a limited amount of drug is dispensed from the pharmacy’s supply) are not problematic if proper controls are in place. Specifically, workable drug sampling programs must (1) provide the elements of pharmaceutical care, (2) result in careful drug control, ensuring patients receive only properly labeled and packaged, unexpired, and recorded drugs, (3) provide access to prescription drugs only through authorized, trained personnel, (4) discourage inappropriate prescribing habits, or (5) do not increase the cost of treatment for all patients.